Total, n = 55 | Men, n = 43 | Women, n = 12 | |
---|---|---|---|
Age, mean years (SD) | 58 (15) | 60 (16) | 53 (14) |
Disease duration, mean years (SD) | 7 (7) | 6 (7) | 9 (8) |
Tophus, n (%) | 7 (13) | 4 (9) | 3 (25) |
Erosive disease, n (%) | 36 (65) | 29 (67) | 7 (58) |
IHD, n (%) | 15 (29) n = 51 | 12 (29), n = 42 | 3 (33), n = 9 |
HT, n (%) | 29 (54) n = 54 | 23 (53), n = 43 | 6 (55), n = 11 |
Dyslipidemia, n (%) | 15 (29) n = 51 | 14 (33), n = 43 | 1 (11), n = 9 |
Diuretic use, n (%) | 16 (29) | 12 (28) | 4 (33) |
ULT at DECT, n (%) | 22 (40) | 16 (37) | 6 (50) |
BMI high ≥30, n (%) | 20 (48) n = 42 | 12 (38), n = 32 | 8 (75), n = 10 |
Urate at DECT, μmol/L, mean (SD) | 457 (134) | 465 (133) | 424 (137) |
Urate at DECT, μmol/L, mean (SD) with ULT, n = 22 | 405 (114) | 401 (93), n = 16 | 418 (168), n = 6 |
Urate at DECT, μmol/L, mean (SD) without ULT, n = 33 | 491 (137) | 504 (140), n = 27 | 429 (113), n = 6 |
eGFR > 90, n (%) | 16 (29) | 12 (28) | 4 (33) |
eGFR 60–90, n (%) | 20 (36) | 15 (35) | 5 (42) |
eGFR < 60, n (%) | 19 (35) | 16 (37) | 3 (25) |